149270-28-0

149270-28-0 structure
149270-28-0 structure
  • Name: [Lys5,MeLeu9,Nle10]Neurokinin A(4-10)
  • Chemical Name: [Lys5,MeLeu9,Nle10]Neurokinin A(4-10)
  • CAS Number: 149270-28-0
  • Molecular Formula: C39H64N8O10
  • Molecular Weight: 804.97
  • Catalog: Signaling Pathways GPCR/G Protein Neurokinin Receptor
  • Create Date: 2023-02-04 18:39:42
  • Modify Date: 2024-01-12 17:18:52
  • [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) (LMN-NKA), an analogue of Neurokinin A, is a selective and potent NK2R agonist. [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) has prokinetic activity. [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) can be used to study the roles of the NK-2 receptor in smooth muscle contraction in numerous tissues[1][2][3].

Name [Lys5,MeLeu9,Nle10]Neurokinin A(4-10)
Description [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) (LMN-NKA), an analogue of Neurokinin A, is a selective and potent NK2R agonist. [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) has prokinetic activity. [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) can be used to study the roles of the NK-2 receptor in smooth muscle contraction in numerous tissues[1][2][3].
Related Catalog
Target

NK2

In Vivo [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) (30-100 μg/kg,皮下注射) 增加了小型猪的膀胱和结肠直肠压力峰值[1]。 [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) (0.3 μg/kg 静脉注射或 100 μg/kg 鼻腔吸入) 也会增加膀胱和结肠直肠压力[1]。 [Lys5,MeLeu9,Nle10]Neurokinin A(4-10) (10-100 μg/kg,静脉注射,每天四次,连续六天) 在有意识的狗中引起排尿和排便、呕吐和低血压[2]. Animal Model: Anesthetized minipigs[1] Dosage: 30-100 μg/kg Administration: Subcutaneous injection (s.c.) Result: Showed significant, non-linear, dose-dependent increase in peak bladder and colorectal pressures, and was blocked by GR 159897 (HY-107691)(1 mg/kg i.v., 15 min prior to LMN-NKA). Animal Model: Conscious dogs[2] Dosage: 10-100 μg/kg Administration: Intravenous injection (i.v.), four times daily for six consecutive days. Result: Elicited NK2 receptor-mediated micturition defecation and NK1 receptor-mediated emesis and hypotension.
References

[1]. Rupniak NMJ, et al. Prokinetic effects of the neurokinin NK2 receptor agonist [Lys5,MeLeu9,Nle10]-NKA(4-10) on bladder and colorectal activity in minipigs. Neuropeptides. 2019 Oct;77:101956.  

[2]. Rupniak NMJ, et al. [Lys5,MeLeu9,Nle10]-NKA(4-10) Elicits NK2 Receptor-Mediated Micturition and Defecation, and NK1 Receptor-Mediated Emesis and Hypotension, in Conscious Dogs. J Pharmacol Exp Ther. 2018 Jul;366(1):136-144.  

[3]. Sara Good, et al. [Lys5, MeLeu9, Nle10]NKA-4-10. Reference Module in Biomedical Sciences. 2019.

Molecular Formula C39H64N8O10
Molecular Weight 804.97
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.